The effect of latanoprost on circadian intraocular pressure

Survey of Ophthalmology

Volumn 47, Issue 4 SUPPL. 1, 2002, Pages

  Larsson, Lill Inger ^a   Mishima, Hiromu K ^b   Takamatsu, Michiya ^b   Orzalesi, Nicola ^c   Rossetti, Luca ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Circadian; Diurnal; Intraocular pressure; Latanoprost; Nocturnal; Timolol

Indexed keywords

ANTIHYPERTENSIVE AGENT; DORZOLAMIDE; LATANOPROST; TIMOLOL;

AQUEOUS HUMOR FLOW; AQUEOUS SOLUTION; CIRCADIAN RHYTHM; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; CARBONIC ANHYDRASE INHIBITORS; CIRCADIAN RHYTHM; GELS; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS F, SYNTHETIC; RANDOMIZED CONTROLLED TRIALS; SULFONAMIDES; THIOPHENES; TIMOLOL;

EID: 0036669662     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(02)00296-5     Document Type: Review

References (36)

1. Alm A., Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. Ophthalmology. 102:1995;1743-1752.
2. Alm A., Widengard I., Kjellgren D.et al. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol. 79:1995;12-16.
3. Bito L.Z. The impact of intraocular pressure on venous outflow from the globe. a hypothesis regarding IOP-dependent vascular damage in normal-tension and hypertensive glaucoma J Glaucoma. 5:1995;127-134.
4. Bito L.Z. Glaucoma. a physiologic perspective with Darwinian overtones J Glaucoma. 1:1992;193-205.
5. Brown B., Burton P., Mann S., Parisi A. Fluctuations in intra-ocular pressure with sleep. II. Time course of IOP decrease after waking from sleep Ophthalmic Physiol Opt. 8:1988;249-252.
6. Brown B., Morris P., Muller C.et al. Fluctuations in intra-ocular pressure with sleep. I. Time course of IOP increase after the onset of sleep Ophthalmic Physiol Opt. 8:1988;246-248.
7. Brubaker R.F. Delayed functional loss in glaucoma. LII Edward Jackson memorial lecture. Am J Ophthalmol. 121:1996;473-483.
8. Buguet A., Py P., Romanet J.P. 24-hour (nyctohemeral) and sleep-related variations of intraocular pressure in healthy white individuals. Am J Ophthalmol. 117:1994;342-347.
9. Drance S.M. The significance of the diurnal tension variations in normal and glaucomatous eyes. Arch Ophthalmol. 64:1960;494-501.
10. Ericson L.A. Twenty-four hourly variations of the aqueous flow. Acta Ophthalmol. 36(Suppl):1958;1-95.
11. Frampton P., Da Rin D., Brown B. Diurnal variation of intraocular pressure and the overriding effects of sleep. Am J Optom Physiol Opt. 64:1987;54-61.
12. Graham S.L., Drance S.M., Wijsman K.et al. Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip. Ophthalmology. 102:1995;61-69.
13. Hayreh S.S., Zimmerman M.B., Podhajsky P., Alward W.L. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 117:1994;603-624.
14. Ingram C.J., Brubaker R.F. Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes. Am J Ophthalmol. 128:1999;292-296.
15. Kiuchi Y., Takamatsu M., Mishima H.K. PhXA41, a prostaglandin F2-analogue reduces the intraocular pressure (IOP) in human volunteers during day and night. Invest Ophthalmol Vis Sci. 35(Suppl):1994;2178. [abstract].
16. Konstas A.G., Mantziris D.A., Stewart W.C. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 115:1997;182-185.
17. Krag S., Andersen H.B., Sorensen T. Circadian intraocular pressure variation with beta-blockers. Acta Ophthalmol Scand. 77:1999;500-503.
18. Larsson L.I. Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension. Ophthalmology. 108:2001;1439-1444.
19. Larsson L.I. Intraocular pressure over 24 hours after single-dose administration of latanoprost 0.005% in healthy volunteers. A randomized, double-masked, placebo controlled, cross-over single center study. Acta Ophthalmol Scand. 79:2001;567-571.
20. Larsson L.I., Rettig E.S., Brubaker R.F. Aqueous flow in open-angle glaucoma. Arch Ophthalmol. 113:1995;283-286.
21. Larsson L.I., Rettig E.S., Sheridan P.T., Brubaker R.F. Aqueous humor dynamics in low-tension glaucoma. Am J Ophthalmol. 116:1993;590-593.
22. Liu J.H., Kripke D.F., Hoffman R.E.et al. Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci. 39:1998;2707-2712.
23. Liu J.H.K. Circadian rhythm of intraocular pressure. J Glaucoma. 7:1998;141-147.
24. McCannel C.A., Heinrich S.R., Brubaker R.F. Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans. Graefes Arch Clin Exp Ophthalmol. 230:1992;518-520.
25. Mishima HK, Kiuchi Y, Takamatsu M, et al: Circadian intraocular pressure management with latanoprost: Diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow. Surv Ophthalmol 41(Suppl 2):S139-44, 197
26. Nagasubramanian S., Sheth G.P., Hitchings R.A., Stjernschantz J. Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens. Ophthalmology. 100:1993;1305-1311.
27. Nilsson S.F., Samuelsson M., Bill A., Stjernschantz J. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey. Exp Eye Res. 48:1989;707-716.
28. Orzalesi N., Rossetti L., Invernizzi T.et al. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci. 41:2000;2566-2573.
29. Reiss G.R., Lee D.A., Topper J.E., Brubaker R.F. Aqueous humor flow during sleep. Invest Ophthalmol Vis Sci. 25:1984;776-778.
30. Stjernschantz J, Selén G, Sjöquist B, Resul B: Preclinical pharmacology of latanoprost, a phenylsubstituted PG F2α-analogue, in Samuelsson B (ed): Advances in Prostaglandin, Tromboxane, and Leukotriene Research, Vol 23. New York, Raven Press, pp 513-8
31. Topper J.E., Brubaker R.F. Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep. Invest Ophthalmol Vis Sci. 26:1985;1315-1319.
32. Wildsoet C., Brown B., Swann P.G. Darkness and sleep as contributing factors to diurnal variation in intraocular pressure. J Glaucoma. 12:1990;140-147.
33. Wildsoet C., Eyeson-Annan M., Brown B.et al. Investigation of parameters influencing intraocular pressure increases during sleep. Ophthalmic Physiol Opt. 13:1993;357-365.
34. Wilensky J.T. Diurnal variations in intraocular pressure. Trans Am Ophthalmol Soc. 89:1991;757-790.
35. Zeimer R.C. Circadian variations in intraocular pressure. Ritch R., Shields M.B., Krupin T. The Glaucomas. 1996;429-445 Mosby, St Louis.
36. Ziai N., Dolan J.W., Kacere R.D., Brubaker R.F. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol. 111:1993;1351-1358.